Conagra Brands Slashes Dividend by 50% as New CEO Moves to Strengthen Finances
CEO John Brase targets higher brand spending amid weak outlook and big impairment charge.
Already have an account? Sign in.
CEO John Brase targets higher brand spending amid weak outlook and big impairment charge.
Xos secures its first U.S. Air Force contract to build a military-grade Xos Hub mobile charging system, marking its entry into defense.
Topline data from Amylyx’s Phase 3 LUCIDITY trial of avexitide for PBH arrives August 18. Prior results and unmet need fuel optimism.
4D Molecular gains support as B. Riley views EyePoint’s Phase 3 setback as favorable for its lead gene therapy candidate 4D-150.